Interventions in chronic pain management. 5. Disease-specific issues in chronic pain

Archives of Physical Medicine and Rehabilitation

Volumn 84, Issue 3, 2003, Pages

  Rashbaum, Ira G ^a   Lacerte, Michel ^b   Braverman, Debra L ^c   Ericksen, Jeffery J ^d  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acupuncture; Biofeedback (psychology); Complex regional pain syndromes; Exercise; Fibromyalgia; Manipulation therapy; Massage; Mind body and relaxation techniques; Multiple sclerosis; Neuralgia; Pain; Rehabilitation

Indexed keywords

ALPRAZOLAM; ANALGESIC AGENT; BENZODIAZEPINE DERIVATIVE; CODEINE; CYCLOBENZAPRINE; FLUOXETINE; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ACUPUNCTURE; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC PAIN; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMPLEX REGIONAL PAIN SYNDROME; DIAGNOSTIC PROCEDURE; DRUG HYPERSENSITIVITY; FEEDBACK SYSTEM; FIBROMYALGIA; HUMAN; MANIPULATIVE MEDICINE; MASSAGE; MULTIPLE SCLEROSIS; PHILOSOPHY; POSTHERPETIC NEURALGIA; RELAXATION TRAINING; REVIEW; TREATMENT INDICATION;

EID: 0037336103     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1053/apmr.2003.50051     Document Type: Article

References (37)

1. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
2. Hadhazy VA, Ezzo J, Creamer P, Berman BM. Mind-body therapies for the treatment of fibromyalgia: a systematic review. J Rheumatol 2000;27:2911-8.
3. Bennett RM. Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc 1999;74:385-98.
4. Pioro-Boisset M, Esdaile JM, Fitzcharles MA. Alternative medicine use in fibromyalgia syndrome. Arthritis Care Res 1996;9:13-7.
5. Leventhal LJ. Management of fibromyalgia. Ann Intern Med 1999;131:850-8. Comment in: Ann Intern Med 2000;132:1004-5.
6. Goldenberg DL. Fibromyalgia syndrome a decade later: what have we learned? Arch Intern Med 1999;159:777-85.
7. Carette S, Bell MJ, Reynolds WJ, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, double-blind clinical trial. Arthritis Rheum 1994;37:32-40.
8. Caruso I, Sarzi Puttini P, Cazzola M, Azzollini V. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 1990;18:201-9.
9. Bennett RM, Clark SC, Walczyk J. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 1998;104:227-31.
10. Berman BM, Swyers JP. Complementary medicine treatments for fibromyalgia syndrome. Baillieres Best Pract Res Clin Rheumatol 1999;13:487-92.
11. Turk DC, Okifuji A, Sinclair JD, Starz TW. Pain, disability, and physical functioning in subgroups of patients with fibromyalgia. J Rheumatol 1996;23:1255-62.
12. NIH Consensus Conference. Acupuncture, JAMA 1998;280:1518-24.
13. Sim J, Adams N. Physical and other non-pharmacological interventions for fibromyalgia. Baillieres Best Pract Res Clin Rheumatol 1999;13:507-23.
14. Pöyhiä R, Da Costa D, Fitzcharles MA. Pain and pain relief in fibromyalgia patients followed for three years. Arthritis Rheum 2001;45:355-61.
15. Dejerine J, Roussy J. Le syndrome thalamique. Rev Neurol 1906;4:521-32.
16. Brust JC. Cerebral infarction. In: Merritt HH, Rowland LP, editors. Merritt's textbook of neurology. 9th ed. Baltimore: Williams & Wilkins; 1995. p 252.
17. Bowsher D. The management of central post-stroke pain. Neurology 1995;71:598-604.
18. Tasker RR. Central pain states. In: Loeser JD, Butler SH, Chapman CR, Turk DC, editors. Bonica's management of pain. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p 433- 57.
19. Hulsebosch CE, Xu GY, Perez-Polo JR, Westlund KN, Taylor CP, McAdoo DJ. Rodent model of chronic central pain after spinal cord contusion injury and effects of gabapentin. J Neurotrauma 2000:17:1205-17.
20. Kapadia NP, Harden N. Gabapentin for chronic pain in spinal cord injury: a case report. Arch Phys Med Rehabil 2000;81:1439-41.
21. Archibald CJ, McGrath PJ, Ritvo PG, et al. Pain prevalence, severity and impact in a clinical sample of multiple sclerosis patients. Pain 1994;58:89-93.
22. Maloni HW. Pain in multiple sclerosis: an overview of its nature and management. J Neurosci Nurs 2000;32:139-44, 152.
23. Cutter NC, Scott D, Johnson JC, Whiteneck G. Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial. Arch Phys Med Rehabil 2000;81:164-9.
24. Villarosa L. Protecting the knees of athletic girls long before the whistle blows. New York Times 2001 Sept 11; sect. P:F5.
25. Van de Loo DA, Johnson MD. The young female athlete. Clin Sports Med 1995;14:687-707.
26. Iobst CA, Stanitski CL. Acute knee injuries. Clin Sports Med 2000;19:621-35, vi.
27. Harmon KG, Ireland ML. Gender differences in noncontact anterior cruciate ligament injuries. Clin Sports Med 2000;19:2;287-302.
28. Brown CH Jr, Carson EW. Revision anterior cruciate ligament surgery. Clin Sports Med 1999;18:109-71.
29. Galer BS, Schwartz L, Allen RJ. Complex regional pain syndromes - type I: reflex sympathetic dystrophy, and type II: causalgia. In: Loeser JD, Butler SH, Chapman CR, Turk DC, editors. Bonica's management of pain. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 2001. p 388-411.
30. Galer BS, Argoff CE. Zoster and postherpetic neuralgia: pain mechanisms and current management. In: Aronoff GM, editor. Evaluation and treatment of chronic pain. 3rd ed. Baltimore: Williams & Wilkins; 1999.
31. Whitley RJ, Weiss H, Gnann J, et al. The efficacy of steroid and acyclovir therapy of herpes zoster in the elderly [abstract]. J Invest Med 1995;43 Suppl 2:252A.
32. Watson CP, Chipman M, Reed K, Evans RJ, Birkett N. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double blind, crossover trial. Pain 1992;48:29-36.
33. Rowbotham M, Harden N, Stacey B, Berstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia. JAMA 1998;280:1837-42.
34. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991;41:1024-8.
35. Galer BS, Harle J, Rowbotham MC. Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study. J Pain Symptom Manage 1996;12:161-7.
36. Rowbotham MC, Davies PJ, Verkempinck CM, Galer BS. Lidocaine patched: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44.
37. Bernstein JE, Korman NJ, Bidkers DR, Dahl MV, Millikan LE. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 1989;21(2 Pt 1):265-70.